Efficacy of 12-week continuous application lipids derived from animal at two dosage levels on scalp barrier function

Efficacy of 12-week continuous application lipids derived from animal at two dosage levels on scalp barrier function: a randomized, single-blind trial - Efficacy of 12-week continuous application lipids derived from animal at two dosage levels on scalp barrier function

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000059262

Enrollment

Registered

2025-10-06

Start date

2025-10-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Duration: one week 0.001% lipids derived from animal Solution Duration: one week 0.01% lipids derived from animal solution

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Japanese 2. Men or women 3. Adults 4. Healthy individuals 5. Individuals who are concerned about scalp dryness in daily life

Exclusion criteria

Exclusion criteria: 1. Individuals currently receiving medication or outpatient treatment for any serious medical condition 2. Individuals who are undergoing exercise or alimentary therapy under medical supervision 3. Individuals with skin or scalp conditions, including atopic dermatitis, contact dermatitis, skin hypersensitivity, or scalp redness and itchiness 4. Individuals with allergic diseases, including egg allergy 5. Individuals with extremely irregular lifestyle habits, such as diet or sleep 6. Individuals who have been enrolled in other clinical studies within the last 28 days before the agreement to participate in this study or plan to participate in another study during this study

Design outcomes

Primary

Measure	Time frame
Comparison of changes in TEWL across subjects at each assessment week	—

Secondary

Measure	Time frame
Comparison of actual TEWL measurements among individual subjects at each assessment week	—

Countries

Japan

Contacts

Public ContactKayoko Yamaguchi

Pharma Foods International Co., Ltd. R&D Department

Kayoko-yamaguchi@pharmafoods.co.jp075-748-9829

Outcome results